General MedicationsINTRAMUSCULAR, INTRAVENOUSStandard

MAGNESIUM SULFATE

Standard Dose

5GM/10ML (500MG/ML)

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview MAGNESIUM SULFATE is listed in Drugs@FDA under application 019316 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient MAGNESIUM SULFATE Form and strength SOLUTION;INTRAMUSCULAR, INTRAVENOUS - 5GM/10ML (500MG/ML) Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2018-03-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview MAGNESIUM SULFATE is listed in Drugs@FDA under application 019316 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MAGNESIUM SULFATE Form and strength SOLUTION;INTRAMUSCULAR, INTRAVENOUS - 5GM/10ML (500MG/ML) Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2018-03-05 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.